Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Croatia Czechia Denmark Germany +12
  • Study of inhaled interferon beta-1a (SNG001) for treatment of patients with viral lower respiratory tract infections who require mechanical ventilation

    Not recruiting

    2 1
    Investigated drugs:
    Belgium France The Netherlands Spain
  • Study of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments

    Not recruiting

    3 1
    Investigated drugs:
    Belgium France Germany Hungary Italy Poland +1
  • Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Finland France Germany Greece +9
  • Study on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not recruiting

    3 1 1 1
    France Germany Italy Spain
  • Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

    Not recruiting

    3 1 1
    Investigated diseases:
    Bulgaria Czechia Hungary Poland Portugal Slovakia +1
  • Evaluation of Retinol Palmitate Administration and Serum Levels in Preterm Infants with Bronchopulmonary Dysplasia: A Phase 2a Open-Label Study

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    2 1
    Germany Spain
  • Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Not recruiting

    4 1 1 1
    Austria Belgium Bulgaria Czechia France Germany +7
  • Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Hungary Ireland Italy +4